Your browser doesn't support javascript.
loading
REFLECT-a phase 3 trial comparing efficacy and safety of lenvatinib to sorafenib for the treatment of unresectable hepatocellular carcinoma: an analysis of Japanese subset.
Yamashita, Tatsuya; Kudo, Masatoshi; Ikeda, Kenji; Izumi, Namiki; Tateishi, Ryosuke; Ikeda, Masafumi; Aikata, Hiroshi; Kawaguchi, Yasunori; Wada, Yoshiyuki; Numata, Kazushi; Inaba, Yoshitaka; Kuromatsu, Ryoko; Kobayashi, Masahiro; Okusaka, Takuji; Tamai, Toshiyuki; Kitamura, Chifumi; Saito, Kenichi; Haruna, Katsuya; Okita, Kiwamu; Kumada, Hiromitsu.
Afiliação
  • Yamashita T; Department of Gastroenterology, Kanazawa University, Kanazawa, Japan. ytatsuya@m-kanazawa.jp.
  • Kudo M; Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka, Japan.
  • Ikeda K; Department of Hepatology, Toranomon Hospital, Tokyo, Japan.
  • Izumi N; Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Musashino, Japan.
  • Tateishi R; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Ikeda M; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Aikata H; Department of Gastroenterology and Metabolism, Hiroshima University, Hiroshima, Japan.
  • Kawaguchi Y; Department of Hepatobiliary and Pancreatology, Saga-Ken Medical Center Koseikan, Saga, Japan.
  • Wada Y; Department of Gastroenterology, Asakura Medical Association Hospital, Asakura, Japan.
  • Numata K; Department of Hepato-Biliary-Pancreatic Surgery, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.
  • Inaba Y; Gastroenterological Center, Yokohama City University Medical Center, Yokohama, Japan.
  • Kuromatsu R; Department of Diagnostic and Interventional Radiology, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Kobayashi M; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Okusaka T; Department of Hepatology, Toranomon Hospital, Tokyo, Japan.
  • Tamai T; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Kitamura C; Eisai Co., Ltd., Tokyo, Japan.
  • Saito K; Eisai Co., Ltd., Tokyo, Japan.
  • Haruna K; Eisai Co., Ltd., Tokyo, Japan.
  • Okita K; Eisai Co., Ltd., Tokyo, Japan.
  • Kumada H; Department of Hepatology, Shunan Memorial Hospital, Kudamatsu, Japan.
J Gastroenterol ; 55(1): 113-122, 2020 Jan.
Article em En | MEDLINE | ID: mdl-31720835
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Quinolinas / Carcinoma Hepatocelular / Sorafenibe / Neoplasias Hepáticas / Antineoplásicos Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Quinolinas / Carcinoma Hepatocelular / Sorafenibe / Neoplasias Hepáticas / Antineoplásicos Idioma: En Ano de publicação: 2020 Tipo de documento: Article